Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-Barré syndrome

Immune checkpoint inhibitors (ICIs) have revolutionized hepatocellular carcinoma (HCC) treatment, while immune-related adverse events (IRAEs) pose significant challenges. We report a 60-year-old male with unresectable HCC who developed Guillain-Barré syndrome (GBS), a rare but severe neurologic comp...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Lin Ye, Wan Rong Yue, Hao Shi, Jian Ren Li, Yu Ya Qun
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2025-03-01
Serier:	Frontiers in Immunology
Fag:	hepatocellular carcinoma immune checkpoint inhibitor immune-related adverse events Guillain-Barré syndrome neurologic adverse events ICI rechallenge
Online adgang:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1546886/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!